Keyphrases
Active Targeting
12%
Annexin A2 (ANXA2)
17%
Bifunctional
14%
Bone Metastasis
12%
Bone-targeting
11%
Breast Cancer Cells
9%
Cabazitaxel
12%
Cancer Cell Membrane
9%
Cancer Cells
17%
Cancer Diagnosis
12%
Cancer Therapy
21%
Chemotherapy
12%
Clinical Trials
8%
Combination Regimen
12%
Controller
12%
Curcumin
60%
Direct-acting Antivirals
12%
Dissolved Oxygen
12%
Drug Delivery
9%
Fed-batch
15%
Fed-batch Fermentation
13%
Fluorescence Detection
12%
In Cancer
24%
Liposomal Curcumin
10%
Lung
10%
Lung Metastasis
10%
Main Protease Inhibitor
12%
Matrix metalloproteinase-9 (MMP-9)
12%
Metastatic Breast Cancer
8%
Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
15%
Methionine
16%
Methionine Metabolism
25%
Molnupiravir
8%
Nanocurcumin
10%
Nanoparticles
71%
Nasal
9%
Non-covalent
12%
Pancreatic Cancer
14%
Pancreatic Tumor
8%
Particle Size
10%
Paxlovid
12%
PLGA Nanoparticles
18%
Poly(d,l-lactide-co-glycolide)
9%
Poly(lactic-co-glycolic acid) Nanoparticles
9%
Polymeric Nanoparticles
26%
Proof of Concept Study
14%
Prostate Cancer Cells
9%
Synergistic Interaction
12%
Therapeutic Efficacy
9%
Tumor
10%
Pharmacology, Toxicology and Pharmaceutical Science
Alendronic Acid
6%
Antivirus Agent
12%
Bioavailability
7%
Biodistribution
6%
Bone Lesion
6%
Bone Metastasis
8%
Brain Derived Neurotrophic Factor
6%
Cabazitaxel
12%
Cell Culture
6%
Chemotherapy
14%
Chitosan
6%
Clinical Trial
8%
Combination Therapy
10%
Cryptosporidium
6%
Curcumin
49%
Cytokine
6%
Dendrimer
6%
Dihydrofolate Reductase
6%
Disease
9%
Gemcitabine
5%
Hypoxia
6%
Lipocortin
6%
Lipocortin 2
12%
Lung Metastasis
9%
Lung Tumor
6%
Malignant Neoplasm
69%
Metastatic Breast Cancer
18%
Microsphere
6%
Monoclonal Antibody
6%
Nanocarrier
7%
Nanoparticle
100%
Neoplasm
28%
Non Small Cell Lung Cancer
6%
Nose Tumor
6%
Pancreas Cancer
16%
Pancreas Tumor
8%
Poloxamer
6%
Poly(amidoamine)
7%
Polyglactin
10%
Primary Tumor
6%
Prostate Cancer
15%
Proteinase Inhibitor
12%
QT Prolongation
6%
SARS Coronavirus
10%
Sustained Release
7%
Taxane
6%
Thymidylate Synthase
6%
Triazine
6%
Tumor Antigen
6%
Tumor Growth
8%